$STXS
Stereotaxis, Inc. Common Stock
XASE•Health Care•Electromedical & Electrotherapeutic Apparatus
Stereotaxis, Inc. Common Stock
XASE•Health Care•Electromedical & Electrotherapeutic Apparatus
Why is STXS down today? It is at $0.942 (-6.71%), and our scanner flagged it 79 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment STXS spikes, and full due diligence on STXS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $STXS 79 times in the last 30 days. Create a free account to track $STXS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how STXS traded in the last session, Friday (last price and move above). Our scanner fired 17 unusual-volume and momentum alerts on STXS on Friday, peaking at 81.9x its normal volume.
Likely catalystStereotaxis, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filingDFiling (D)Nov 18, 2026 · 3 days agoAcross every filing on file, supply equal to at least 189.5% of the tradeable float is in play - 189.5% more can still be issued.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
76,432,947 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Isaac Paul J Director | Bought (open market) | +300 | added <0.1% | 2.80M | $240 at $0.800 | Nov 17, 26 |
Benfer David Director | Bought (open market) | +30K 0.03% of company | added 14% | 243K | $25K at $0.830 | Nov 17, 26 |
Menawat Arun Swarup Director | Bought (open market) | +122K 0.1% of company | added 12% | 1.16M | $100K at $0.820 | Nov 17, 26 |
Isaac Paul J Director | Bought (open market) | +13K 0.01% of company | added 0.5% | 2.80M | $11K at $0.820 | Nov 16, 26 |
Curet Myriam Director | Acquired (grant/award) | +43K 0.04% of company | added 11% | 435K | n/a | Jul 1, 26 |
Menawat Arun Swarup Director | Acquired (grant/award) | +43K 0.04% of company | added 4.3% | 1.04M | n/a | Jul 1, 26 |
Fischel Nathan Director | Acquired (grant/award) | +43K 0.04% of company | added 6.4% | 721K | n/a | Jul 1, 26 |
Levin Ross B Director | Acquired (grant/award) | +43K 0.04% of company | added 7.5% | 621K | n/a | Jul 1, 26 |
Shamir Nachum Director | Acquired (grant/award) | +43K 0.04% of company | added 32% | 179K | n/a | Jul 1, 26 |
Benfer David Director | Acquired (grant/award) | +43K 0.04% of company | added 8.4% | 559K | n/a | Jul 1, 26 |
Fischel Nathan Director | Acquired (grant/award) | +47K 0.05% of company | added 7.4% | 678K | n/a | Jan 2, 26 |
Levin Ross B Director | Acquired (grant/award) | +47K 0.05% of company | added 8.8% | 578K | n/a | Jan 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in electromedical & electrotherapeutic apparatus, closest in size first.
The market is closed. Here is how STXS traded in the last session, Friday (last price and move above). Our scanner fired 17 unusual-volume and momentum alerts on STXS on Friday, peaking at 81.9x its normal volume.
STXS last traded at $0.942, down 6.71% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The STXS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged STXS 79 times in the last 30 days.
STXS (Stereotaxis, Inc. Common Stock) trades on XASE, with a market cap of about $95M in the Electromedical & Electrotherapeutic Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge STXS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$STXS discussion
Sign in to ask a question or join the discussion.